News | May 29, 2022
JBCL rebrands as JB
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
The two-day event will showcase achievements and address issues pertaining to the industry
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
Price was the key driver for the period
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
Subscribe To Our Newsletter & Stay Updated
